https://doctransparency.com/doctor/tx/plano/seemal-desai-1669686804
Medicare Enrolled

Dr. Seemal Desai, MD

Dermatology · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
5655 W SPRING CREEK PKWY STE 105, Plano, TX 75024
2149193500
In practice since 2007 (18 years)
NPI: 1669686804 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Desai

Dr. Seemal Desai is a dermatology in Plano, TX, with 18 years in practice. Based on federal Medicare data, Dr. Desai performed 2,519 Medicare services across 1,320 unique beneficiaries.

Between the years covered by Open Payments, Dr. Desai received a total of $549,215 from 39 pharmaceutical and/or device companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 46% volume in TX$ $549,215 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,519
Medicare services
Top 46% in TX for dermatology
1,320
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-14939$5$14
Office visit, established patient (20-29 min)497$59$186
Destruction of precancerous skin growth, 1230$36$136
Destruction of skin growths (warts/lesions), 1-14206$81$236
Office visit, established patient (30-39 min)184$83$253
Skin biopsy, tangential144$68$217
Office visit, established patient (10-19 min)113$39$115
Biopsy of related skin growth, each additional growth61$38$110
Destruction of precancer skin growth, 15 or more growths47$121$343
New patient office visit (30-44 min)40$65$228
New patient office visit (45-59 min)17$120$340
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)15$306$782
Application of light with debridement to destroy precancer skin growth13$193$606
New patient office or other outpatient visit, 15-29 minutes13$52$149
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$549,215
Total received (2018-2024)
Avg $78,459/year across 7 years
Top 2% in TX for dermatology
39
Companies
448
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$300,156 (54.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$245,939 (44.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,120 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,306
2023
$34,926
2022
$165,159
2021
$125,496
2020
$101,994
2019
$75,357
2018
$43,977

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$181,687
Incyte Corporation
$60,083
E.R. Squibb & Sons, L.L.C.
$56,645
DERMIRA, INC.
$39,160
ABBVIE INC.
$38,201
Ortho Dermatologics, a division of Bausch Health US, LLC
$37,681
Galderma Laboratories, L.P.
$31,594
Almirall LLC
$18,917
LEO Pharma Inc.
$13,419
Lilly USA, LLC
$12,850
Amgen Inc.
$8,845
GENZYME CORPORATION
$7,024
Dermavant Sciences, Inc.
$6,743
Allergan Inc.
$6,415
UCB, Inc.
$6,027
Eli Lilly and Company
$5,678
Janssen Scientific Affairs, LLC
$4,298
Pfizer Inc.
$3,400
AbbVie Inc.
$3,257
Encore Dermatology Inc.
$3,191
Allergan, Inc.
$2,277
Sun Pharmaceutical Industries Inc.
$1,129
Novartis Pharmaceuticals Corporation
$125
Regeneron Healthcare Solutions, Inc.
$98
STRATA Skin Sciences, Inc.
$82
Merz North America, Inc.
$49
Arcutis Biotherapeutics, Inc.
$49
Sensus Healthcare, Inc.
$48
Taro Pharmaceuticals USA, Inc.
$40
Boston Scientific Corporation
$31
Merck Sharp & Dohme Corporation
$25
AbbVie, Inc.
$23
Solta Medical, a division of Bausch Health US, LLC
$20
Kyowa Kirin, Inc.
$20
Verrica Pharmaceuticals Inc.
$20
Genentech USA, Inc.
$18
Janssen Biotech, Inc.
$17
EPI Health, LLC
$15
Celgene Corporation
$15
Top 3 companies account for 54.3% of total payments
Associated products mentioned in payments ›
0.25% · ADBRY · AKLIEF · ALTRENO · ARAZLO · BLU-U · BOTOX · BRYHALI · CIBINQO · COSENTYX · Cabtreo · Cimzia · DUOBRII · DUPIXENT · EPIDUO FORTE · EUCRISA · Enbrel · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · LUMAKRAS · OLUMIANT · ONEXTON · OPZELURA · Olumiant · Otezla · POTELIGEO · QBREXZA · RINVOQ · Rituxan · SEYSARA · SILIQ · SIVEXTRO · SKYRIZI · Seysara · Sitavig · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · ULTRAVATE (halobetasol propionate) lotion · VTAMA · WaveWriter Alpha Prime 16 · XELJANZ · XTRAC · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for dermatology in TX.

Equivalent to $21,803 per 100 Medicare services performed
Looking for a dermatology in Plano?
Compare dermatologys in the Plano area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
207
Per 100K population
18.5
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Desai is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Desai experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Desai performed 939 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $549,215 from 39 companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other dermatologys in Plano?
Dr. Desai's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →